Banner

 

Dr. Matthias Voss

Foto von Matthias Voss
Matthias Voss
Research
CV
News
Group
Publications
Contact
Junior Research Group

Publications

Original Publications

15
Alternative UNC13D Promoter Encodes a Functional Munc13-4 Isoform Predominantly Expressed in Lymphocytes and Platelets.
Galgano D, Soheili T, Voss M, Torralba-Raga L, Tesi B, Cichocki F, Andre I, Rettig J, Cavazzana M, Bryceson Y.
Front Immunol. 2020 Jun 9;11:1154.
 
14
A RAB27A 5' untranslated region structural variant associated with late-onset hemophagocytic lymphohistiocytosis and normal pigmentation.
Tesi B, Rascon J, Chiang SCC, Burnyte B, Löfstedt A, Fasth A, Heizmann M, Juozapaite S, Kiudeliene R, Kvedaraite E, Miseviciene V, Muleviciene A, Müller ML, Nordenskjöld M, Matuzeviciene R, Samaitiene R, Speckmann C, Stankeviciene S, Zekas V, Voss M, Ehl S, Vaiciene-Magistris N, Henter JI, Meeths M, Bryceson YT.
J Allergy Clin Immunol. 2018 Jul;142(1):317-321.e8
 
13
Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7.
Pastor VB, Sahoo SS, Boklan J, Schwabe GC, Saribeyoglu E, Strahm B, Lebrecht D, Voss M, Bryceson YT, Erlacher M, Ehninger G, Niewisch M, Schlegelberger B, Baumann I, Achermann JC, Shimamura A, Hochrein J, Tedgård U, Nilsson L, Hasle H, Boerries M, Busch H, Niemeyer CM, Wlodarski MW.
Haematologica. 2018 Mar;103(3):427-437
 
12
Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms.
Tesi B*, Davidsson J*, Voss M*, Rahikkala E, Holmes TD, Chiang SCC, Komulainen-Ebrahim J, Gorcenco S, Rundberg Nilsson A, Ripperger T, Kokkonen H, Bryder D, Fioretos T, Henter JI, Möttönen M, Niinimäki R, Nilsson L, Pronk CJ, Puschmann A, Qian H, Uusimaa J, Moilanen J, Tedgård U, Cammenga J, Bryceson YT.
Blood. 2017 Apr 20;129(16):2266-2279
 
11
Natural killer cell biology illuminated by primary immunodeficiency syndromes in humans.
Voss M, Bryceson YT.
Clin Immunol. 2017 Apr;177:29-42
 
10
Proteolytic Processing of Neuregulin 1 Type III by Three Intramembrane-cleaving Proteases.
Fleck D, Voss M, Brankatschk B, Giudici C, Hampel H, Schwenk B, Edbauer D, Fukumori A, Steiner H, Kremmer E, Haug-Kröper M, Rossner MJ, Fluhrer R, Willem M, Haass C.
J Biol Chem. 2016 Jan 1;291(1):318-33.
 
9
Secretome analysis identifies novel signal Peptide peptidase-like 3 (Sppl3) substrates and reveals a role of Sppl3 in multiple Golgi glycosylation pathways.
Kuhn PH*, Voss M*, Haug-Kröper M, Schröder B, Schepers U, Bräse S, Haass C, Lichtenthaler SF, Fluhrer R.
Mol Cell Proteomics. 2015 Jun;14(6):1584-98
 
8
Shedding of glycan-modifying enzymes by signal peptide peptidase-like 3 (SPPL3) regulates cellular N-glycosylation.
Voss M, Künzel U, Higel F, Kuhn PH, Colombo A, Fukumori A, Haug-Kröper M, Klier B, Grammer G, Seidl A, Schröder B, Obst R, Steiner H, Lichtenthaler SF, Haass C, Fluhrer R.
EMBO J. 2014 Dec 17;33(24):2890-905
 
7
Differential protein-protein interactions of full length human FasL and FasL fragments generated by proteolysis.
Lettau M*, Voss M*, Ebsen H, Kabelitz D, Janssen O.
Exp Cell Res. 2014 Jan 15;320(2):290-301
 
6
Mechanism, specificity, and physiology of signal peptide peptidase (SPP) and SPP-like proteases.
Voss M, Schröder B, Fluhrer R.
Biochim Biophys Acta. 2013 Dec;1828(12):2828-39. Review
 
5
Foamy virus envelope protein is a substrate for signal peptide peptidase-like 3 (SPPL3).
Voss M, Fukumori A, Kuhn PH, Künzel U, Klier B, Grammer G, Haug-Kröper M, Kremmer E, Lichtenthaler SF, Steiner H, Schröder B, Haass C, Fluhrer R.
J Biol Chem. 2012 Dec 21;287(52):43401-9
 
4
Requirements for leukocyte transmigration via the transmembrane chemokine CX3CL1.
Schwarz N, Pruessmeyer J, Hess FM, Dreymueller D, Pantaler E, Koelsch A, Windoffer R, Voss M, Sarabi A, Weber C, Sechi AS, Uhlig S, Ludwig A.
Cell Mol Life Sci. 2010 Dec;67(24):4233-48
 
3
The adapter protein Nck: role of individual SH3 and SH2 binding modules for protein interactions in T lymphocytes.
Lettau M, Pieper J, Gerneth A, Lengl-Janssen B, Voss M, Linkermann A, Schmidt H, Gelhaus C, Leippe M, Kabelitz D, Janssen O.
Protein Sci. 2010 Apr;19(4):658-69
 
2
Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening.
Voss M*, Lettau M*, Janssen O.
BMC Immunol. 2009 Oct 6;10:53
 
1
Posttranslational regulation of Fas ligand function.
Voss M*, Lettau M*, Paulsen M, Janssen O.
Cell Commun Signal. 2008 Dec 29;6:11
 
Original Publications Back to Top
Letzte Änderung / Last change: Mai 5, 2021